Natera (NTRA) Competitors

Fresenius Medical Care (NYSE:FMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, community ranking, dividends, analyst recommendations, profitability, earnings and valuation.

Is FMS or NTRA more profitable?

Fresenius Medical Care has a net margin of 3.43% compared to Natera's net margin of -14.01%. Fresenius Medical Care's return on equity of 6.04% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care	3.43%	6.04%	2.69%
Natera	-14.01%	-26.23%	-14.27%

Do analysts rate FMS or NTRA?

Fresenius Medical Care presently has a consensus price target of $27.80, suggesting a potential downside of 2.95%. Natera has a consensus price target of $184.63, suggesting a potential upside of 11.74%. Given Natera's stronger consensus rating and higher probable upside, analysts plainly believe Natera is more favorable than Fresenius Medical Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Natera	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals and insiders hold more shares of FMS or NTRA?

8.4% of Fresenius Medical Care shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 7.6% of Natera shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has preferable earnings and valuation, FMS or NTRA?

Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care	$19.49B	0.86	$540.07M	$1.12	25.58
Natera	$1.83B	12.32	-$434.80M	-$1.47	-112.39

Does the media refer more to FMS or NTRA?

In the previous week, Natera had 13 more articles in the media than Fresenius Medical Care. MarketBeat recorded 19 mentions for Natera and 6 mentions for Fresenius Medical Care. Natera's average media sentiment score of 0.84 beat Fresenius Medical Care's score of 0.79 indicating that Natera is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Natera	12 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community favor FMS or NTRA?

Natera received 70 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 68.90% of users gave Natera an outperform vote while only 54.64% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
Fresenius Medical Care	Outperform Votes 424 54.64%	Underperform Votes 352 45.36%
Natera	Outperform Votes 494 68.90%	Underperform Votes 223 31.10%

Which has more volatility and risk, FMS or NTRA?

Fresenius Medical Care has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. Comparatively, Natera has a beta of 1.74, suggesting that its stock price is 74% more volatile than the S&P 500.

Summary

Natera beats Fresenius Medical Care on 11 of the 18 factors compared between the two stocks.